Menopause changes your eyes, and most women are not warned about this. Dry eyes, raised glaucoma risk, AMD, and accelerated cataract development are all linked to the hormonal shifts that begin in perimenopause and continue for years afterward.
As a glaucoma specialist, I see menopausal women in clinic every week who have been managing irritated, uncomfortable eyes for months without anyone connecting the dots to their hormonal status. The eye changes are real, they are treatable, and they matter for your long-term vision.
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.
How Menopause Affects the Eyes
Dry Eyes: The Most Common Change
Dry eyes are the most frequent eye complaint during and after menopause. Estrogen and androgens, the sex hormones that decline during menopause, play a direct role in regulating the eye’s lubrication system. The Meibomian glands, tiny oil-producing glands inside the eyelids, are particularly sensitive to hormonal changes.
These glands produce the lipid layer of the tear film. When this layer thins or becomes unstable, tears evaporate too quickly. The result is stinging, grittiness, redness, and paradoxically, watery eyes, a reflex response to surface dryness.
Dry eye in menopausal women tends to be the evaporative type, driven by Meibomian gland dysfunction, rather than a pure reduction in tear production. This distinction matters because treatment is different. Lubricating drops alone are often not enough. Warm compresses, lid hygiene, and in some cases, prescription therapy, are needed.
Note: Hormonal shifts during pregnancy can affect the eyes in similar ways — if you are planning a family or currently pregnant, eye care during pregnancy is worth reading alongside this article.
Glaucoma Risk After Menopause
Research suggests that estrogen may have a protective effect on the optic nerve and on intraocular pressure regulation. After menopause, as estrogen levels fall, glaucoma risk increases, particularly for open-angle glaucoma, the most common form.
Women who undergo early surgical menopause (removal of ovaries before natural menopause) appear to face a higher glaucoma risk than those who go through natural menopause. This is an area of active and evolving research.
Importantly, glaucoma is silent in its early stages. It does not cause pain, and central vision is preserved until advanced disease. Raised eye pressure alone causes no symptoms. A comprehensive eye examination: including optic nerve imaging and visual field testing, is the only way to detect it early.
If you are perimenopausal or postmenopausal, a baseline glaucoma evaluation is worth having, particularly if you have a family history of glaucoma, high myopia, or other risk factors.
Cataracts
Cataracts, clouding of the eye’s natural lens, are part of normal ageing, but they are more common in women than in men, and the reasons for this are not fully understood. Hormonal factors, longer life expectancy, and greater cumulative UV exposure all likely contribute.
Cataracts cause a gradual, painless blurring of vision, increased glare, and difficulty with night driving. Regular eye examinations allow for timely detection and planning. Surgery, when needed, is highly effective.
Age-Related Macular Degeneration
Age-related macular degeneration (AMD) affects the central part of the retina responsible for sharp, detailed vision. Women account for a disproportionate share of AMD cases globally. Post-menopausal women with AMD risk factors: smoking, family history, cardiovascular disease, benefit from targeted nutritional support (lutein, zeaxanthin, AREDS formulations) and regular retinal review.
What You Can Do
For Dry Eyes
Warm compresses for five minutes twice daily help unblock Meibomian glands and stabilise the tear film. Use a clean warm cloth or a purpose-made eye mask. Preservative-free lubricating drops can be used as often as needed. Reduce screen time where possible, or take regular breaks using the 20-20-20 rule: every 20 minutes, look at something 20 feet away for 20 seconds.
Omega-3 fatty acids, from dietary sources or supplements, have evidence supporting their role in Meibomian gland function and dry eye symptoms. Staying well hydrated and reducing alcohol intake also helps.
For Glaucoma Monitoring
Get a comprehensive eye examination that includes intraocular pressure measurement, optic nerve assessment, and where indicated, OCT imaging and visual field testing. Frequency of follow-up depends on your risk profile. If you already have glaucoma, menopause is a relevant part of your medical history, share it with your glaucoma specialist.
Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.
For General Eye Health
Control cardiovascular risk factors: blood pressure, blood sugar, and cholesterol, as these directly affect retinal and optic nerve health. Protective eyewear outdoors to reduce UV exposure is relevant at every age. Regular eye examinations after 40 are not optional; they are how silent conditions are caught before damage becomes irreversible.
Frequently Asked Questions
Does menopause cause glaucoma?
Menopause does not directly cause glaucoma, but the hormonal changes associated with it, particularly falling estrogen levels, may increase susceptibility to raised intraocular pressure and optic nerve damage over time. The relationship between estrogen and glaucoma is an area of active research. Women who have gone through menopause, especially those with a family history of glaucoma, benefit from regular comprehensive eye examinations.
Can hormone replacement therapy (HRT) protect the eyes?
Some studies suggest that HRT may have a modest effect on intraocular pressure, but this is not a reason to start or continue HRT for eye health alone. The decision to use HRT involves a broader assessment of benefits and risks and should be made in consultation with your physician. If you are already on HRT, mention it to your eye specialist. It is relevant to your complete clinical picture.
Why are my eyes so dry since menopause?
Declining estrogen and androgen levels affect the Meibomian glands, which produce the oily layer of the tear film. Without this protective oil layer, tears evaporate too quickly, leaving the eye surface exposed and uncomfortable. This is called evaporative dry eye and is very common in perimenopausal and postmenopausal women. It is treatable. But the treatment needs to address the underlying gland dysfunction, not just replace tears.
How often should menopausal women have their eyes checked?
At a minimum, a comprehensive eye examination every one to two years after the age of 40 is appropriate for most women. If you have risk factors for glaucoma: family history, high eye pressure, high myopia, or early menopause, annual review is advisable. If you already have a diagnosed eye condition, your specialist will recommend an individualised follow-up schedule.
Can dry eye from menopause be permanent?
Meibomian gland dysfunction, once established, does require ongoing management rather than a one-time cure. However, consistent treatment: warm compresses, lid hygiene, appropriate drops, and dietary measures, significantly improves comfort and protects the gland function that remains. Early attention gives better long-term outcomes. Do not wait until symptoms are severe before seeking help.
Read the research articles
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
Access her work on Pubmed, Google Scholar, ResearchGate and ORCID.
Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care
www.drshibalbhartiya.com
+91 88826 38735
1500+ Five Star Patient Reviews Google Business Profile
Upload your reports for a structured review.
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma
